|  |  | 

India Top Headlines

2DG DRDO: Rajnath Singh Launches Anti-Covid Drug 2-DG (2-Deoxy-D-Glucose) Developed by DRDO | India News

NEW DELHI: Defense Minister Rajnath Singh on Monday launched the first batch of the drug 2-deoxy-D-glucose (2-DG) developed by the Defense Research and Development Organization (DRDO) for the treatment of Covid -19.
The drug’s anti-COVID therapeutic application has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.
The drug comes as a powder in a sachet and is taken by mouth by dissolving it in water, the ministry said.
In efficacy trends, he said, patients treated with 2-DG showed faster symptomatic cure than standard of care (SoC) on several endpoints.
(With PTI inputs)

Original source